Drug Interaction Study With a Potential Alzheimer's Disease Compound

• Status: Completed
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to determine whether BMS-708163 will effect the pharmacokinetics of the commonly prescribed medicines midazolam, warfarin, caffeine,omeprazole and dextromethorphan

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bristol-Myers Squibb
• Treatments: Caffeine; Dextromethorphan; Midazolam; Omeprazole; Vitamin K; Vitamins; Warfarin

Criteria

Inclusion Criteria:

• Healthy male subjects

• 18-45 yrs old inclusive

Exclusion Criteria:

• Women